Recent business and finance press releases & news

Looking for the latest news on the products and services you patronize? Presswire is your go-to website. Presswire is the leading online news and press release distribution service. Used by thousands of organizations of every size to get better visibility, improve their ranks on the search engines, drive traffic to their website, and deliver the latest news to their respective target audiences. Presswire's press release distribution services go to various media outlets in our media contacts database, keeping everyone in-the-know informed. Do you have a news story to feature? Send and create your stories or product and service news to Presswire, but filling out the form here.

1

Axi launches $0 commission Share CFD trading products: Top FX and CFD provider adds stocks to its global offerings

 

[PRESSWIRE] London, UK – 26 August, 2021 -- Award-winning global FX and CFD broker Axi has expanded its range of trading products to include Share CFDs.

1

شركة أكسي (Axi) تطلق أدوات تداول على أسهم عقود الفروقات بعمولة 0 دولار

 

[PRESSWIRE] تضيف أفضل شركة للعملات الأجنبية وعقود الفروقات العديد من الأسهم إلى عروضها العالمية

1

ANIL UZUN Talks about the Importance of Socially Conscious Fintech

 

[PRESSWIRE] London, UK - 24 August, 2021 -- ANIL UZUN will comment on the importance of socially conscious Fintech on Youtube on September 3, Friday at 07.00 pm CET.

1

Armada Cryptocurrency/ Introducing depreciating fees – TIME IS MONEY

 

[PRESSWIRE] London, UK - 22 August, 2021 -- Armada - Debuting Liquid Fees and a truly innovative launchpad!

MUX MINER: NEXT GEN TURNKEY CRYPTOCURRENCY MINING

 

[PRESSWIRE] Canada - 19 August, 2021 -- Mux Miner recently developed a series of Application-Specific Integrated Circuit (ASIC) powered by the MuxMiner independent core technology...

1

Widely available anti-allergy azelastine nasal spray poised to revolutionise COVID-19 management

 

[PRESSWIRE] Vienna -- 17th August 2021 - CEBINA GmbH, Central European Biotech Incubator and Accelerator today announces the publication of the first results of a Phase 2 efficacy clinical trial sponsored jointly with its partner URSAPHARM Arzneimittel GmbH demonstrating that a nasal spray containing the active ingredient azelastine was effective in accelerating the reduction of the viral load in SARS-CoV-2 positive patients. Azelastine has been marketed in an identical composition by URSAPHARM for many years and is used as an antiallergic.

1

Greystone Bel’s Chicago Office Completes Sale of Five-Property Portfolio in Rockford, IL Totaling $43.3 Million

[PRESSWIRE] CHICAGO - August 18, 2021 -- Greystone Bel Real Estate Advisors Chicago Office recently closed the sale of the Hampton Portfolio in Rockford, Illinois for $43.3 million.

1

Interview with Elisabeth Boivin and Nick Hollingworth, Managing Directors at Creating Tomorrow’s Forests

 

[PRESSWIRE] UK - 13 August, 2021 -- The European interviews Elisabeth Boivin and Nick Hollingworth, Managing Directors at Creating Tomorrow’s Forests...

1

ANIL UZUN Comments on the Slow Reaction of Central Banks to Digital Currencies

 

[PRESSWIRE] London, UK - 05 August, 2021 -- ANIL UZUN will talk about how the reaction of central banks to digital currencies is not fast enough to create an impact on Youtube on August 13, Friday at 07.00 pm CET.

1

The European interviews Jane-Michèle Clark of Cloud Managed Networks

 

[PRESSWIRE] London, UK - 28 July, 2021 -- The interview included discussions surrounding cyber security, specifically when utilising the cloud...